Interleukin-2 production in head and neck cancer patients
- 31 October 1985
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 150 (4) , 456-460
- https://doi.org/10.1016/0002-9610(85)90153-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody‐Forming B Cell ResponsesImmunological Reviews, 1982
- The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences.The Journal of Immunology, 1980
- ROLE OF MITOGENIC FACTOR, LYMPHOCYTE-ACTIVATING FACTOR AND IMMUNE INTERFERON IN THE INDUCTION OF HUMORAL AND CELL-MEDIATED IMMUNITYAnnals of the New York Academy of Sciences, 1979
- Immunologic Testing as a Guide to Cancer ManagementSurgical Clinics of North America, 1979
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Immunologic evaluation and prognosis in patients with head and neck cancerThe American Journal of Surgery, 1977
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- T-cell deficiency in patients with squamous cell cancer of the head and neckThe American Journal of Surgery, 1975